Header Logo

Connection

HASHEM EL-SERAG to Liver Diseases

Back to Details
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Liver Diseases.
HASHEM EL-SERAG
Connection Strength
3.736
Liver Diseases
  1. Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. Gastroenterology. 2018 09; 155(3):607-609.
    View in: PubMed
    Score: 0.451
  2. Prediction Models for Gastrointestinal and Liver Diseases: Too Many Developed, Too Few Validated. Clin Gastroenterol Hepatol. 2016 12; 14(12):1678-1680.
    View in: PubMed
    Score: 0.395
  3. The Art and Science of Managing Liver Disease. Clin Gastroenterol Hepatol. 2015 Nov; 13(12):2029-30.
    View in: PubMed
    Score: 0.368
  4. Hepatology 2014: where are we going? Minerva Gastroenterol Dietol. 2014 Mar; 60(1):1-4.
    View in: PubMed
    Score: 0.332
  5. Finasteride and methadone use and risk of advanced hepatitis C related liver disease. Dig Dis Sci. 2012 Nov; 57(11):3004-10.
    View in: PubMed
    Score: 0.294
  6. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology. 2012 Mar; 55(3):759-68.
    View in: PubMed
    Score: 0.285
  7. Efficacy, effectiveness, and comparative effectiveness in liver disease. Hepatology. 2010 Aug; 52(2):403-7.
    View in: PubMed
    Score: 0.259
  8. Genetic association studies: from "searching under the lamppost" to "fishing in the pond". Gastroenterology. 2008 Mar; 134(3):662-4.
    View in: PubMed
    Score: 0.219
  9. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2008 Feb 01; 27(3):274-82.
    View in: PubMed
    Score: 0.214
  10. Translational research: the study of community effectiveness in digestive and liver disorders. Gastroenterology. 2007 Jan; 132(1):8-10.
    View in: PubMed
    Score: 0.202
  11. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004 Feb; 126(2):460-8.
    View in: PubMed
    Score: 0.165
  12. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul; 36(1):227-42.
    View in: PubMed
    Score: 0.148
  13. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020 Jul; 159(1):320-334.e27.
    View in: PubMed
    Score: 0.128
  14. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver?Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):191-202.e1-4; quiz e20.
    View in: PubMed
    Score: 0.092
  15. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009 May; 136(5):1601-8.
    View in: PubMed
    Score: 0.058
  16. Effect of human immunodeficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective. Clin Gastroenterol Hepatol. 2007 Nov; 5(11):1321-1328.e7.
    View in: PubMed
    Score: 0.054
  17. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007 Jun; 132(7):2557-76.
    View in: PubMed
    Score: 0.052
  18. The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther. 2014 Mar; 39(5):518-31.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.